Tacrolimus Injection Breakthrough: FDA Approves Nexus Pharmaceuticals’ Novel Formulation
Written by
Atlas King Content Writer
Written by
Atlas King Content Writer
GLP-1 Weight Loss Drugs: Telehealth Ads Under Scrutiny
X-CGD Treatment Breakthrough: FDA Designations for Ensoma’s EN-374
Evrysdi Tablet for SMA: FDA Approves New Formulation
ADCETRIS Approval: New Hope for Relapsed Large B-Cell Lymphoma Patients
Bird Flu Concerns Rise as US-WHO Communication Falters
Canned Tuna Recall: Major Brands Affected by Potential Botulism Risk
Oyster Recall Expands: FDA Warns of Norovirus Risk
WHO’s Free Cancer Medicines Initiative for Children
Neurofibromatosis Drug Approval: FDA Greenlights Gomekli for NF1 Treatment
Listeria Scare: Massive Doughnut Recall Hits US Stores
Breakthrough in Sepsis Diagnosis: Stanford’s 30-Minute Test
Lerodalcibep: FDA Accepts BLA for Novel PCSK9 Inhibitor
AI-Powered Prostate Cancer Detection: Ibex’s Breakthrough FDA Clearance
Onapgo FDA Approval: A New Option for Advanced Parkinson’s Treatment
Symbravo Migraine Treatment: FDA Approval and Clinical Insights
Onc.AI Breakthrough: FDA Designation for AI-Driven Oncology Tool
